Virtual Meeting to be held on March 22 hosted by Lake Street.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OPTN:
- Optinose price target raised to $4 from $3 at Lake Street
- OptiNose trading resumes
- OptiNose Inc: FDA Approval and Future Pediatric Study for XHANCE
- Optinose to resume trading at 4:20 pm ET
- XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps